Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

bankerson

Rank: Treasurer [?]

Points: 22820 [?]

Votes: 138 Score: 2.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

in response to

Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

greybeard

posted on Apr 17, 2012 09:46AM

Thanks for posting the news. I just was checking up on the stock and saw it has gapped up to $2.32 ? I thought there must be news and looked here. Sure enough you had the news posted. Thanks again.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply